Early research (Phase 1)Study completedNCT01736462
What this trial is testing
Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 Days
Who this might be right for
Corneal Endothelial Cell Changes
Bausch & Lomb Incorporated 61